Home > Press > Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs
Abstract:
Iranian researchers produced anti-breast-cancer drug by using Artemisia annua plant.
The drug has been produced and analyzed at laboratorial scale, and it has successful effects in reducing the size of breast cancer tumors in animal samples.
Artemisinin is the active pharmaceutical ingredient (API) of Artemisia annua plant. Artemisinin has more toxicity on cancer cells in the presence of iron and transferrin. In this research, targeted magnetic nanoliposomes containing artemisinin and holo-transferrin were produced and in-vitro studies were carried out on their anticancer effect on breast cancer cells (MCF-7). In-vivo studies were also carried out on mice suffering from breast cancer.
Based on the results, the functionalization of nanoliposomes with magnetic iron nanoparticles facilitates drug delivery to the tumors. In addition, a significant increase is observed in the efficiency of the entrapped drug in the elimination of breast tumor in the sample animals.
According to the researchers, magnetic nanoliposomes containing artemisinin and transferrin were produced in this research through extrusion method, and some of their physical and chemical properties were studied. Next, in-vitro studies were carried out on the toxicity of the produced nanoliposomes through MTT method on MCF-7 cancer cells.
Results showed that the amount of artemisinin and transferrin in the tumor increased 10 and 5.5 times respectively in comparison with the complex created with the free form of the drugs two hours after the injection of magnetic nanoliposomes containing medication in the presence of magnetic field. In addition, the tumor volume in the sample mice significantly reduced in 15 days due to the presence of the magnetic field.
Results of the research have been published in PHARMACOGNOSY MAGAZINE, vol. 11, issue 42, 2015, pp. 117-122.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press |
News and information
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
MXene nanomaterials enter a new dimension Multilayer nanomaterial: MXene flakes created at Drexel University show new promise as 1D scrolls January 30th, 2026
Cancer
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||